Literature DB >> 29365202

Pediatric low-grade gliomas: a brave new world.

Joshua B Rubin1, Jonathan L Finlay2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29365202      PMCID： PMC5777489          DOI： 10.1093/neuonc/nox221

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

1.  Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group.

Authors:  Joann L Ater; Tianni Zhou; Emiko Holmes; Claire M Mazewski; Timothy N Booth; David R Freyer; Ken H Lazarus; Roger J Packer; Michael Prados; Richard Sposto; Gilbert Vezina; Jeffrey H Wisoff; Ian F Pollack
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Everolimus for neurological and psychiatric diseases: Friend or foe?

Authors:  Zhe-Cheng Jiang; Huan Li; Bin Zhu
Journal:  J Psychiatr Res       Date:  2016-06-23       Impact factor: 4.791

3.  A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†.

Authors:  Murali Chintagumpala; Sandrah P Eckel; Mark Krailo; Michael Morris; Adekunle Adesina; Roger Packer; Ching Lau; Amar Gajjar
Journal:  Neuro Oncol       Date:  2015-04-07       Impact factor: 12.300

Review 4.  Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.

Authors:  Amanda K Tilot; Thomas W Frazier; Charis Eng
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

5.  Neurofibromatosis type 1 and autism spectrum disorder.

Authors:  Shruti Garg; Jonathan Green; Kathy Leadbitter; Richard Emsley; Annukka Lehtonen; D Gareth Evans; Susan M Huson
Journal:  Pediatrics       Date:  2013-11-04       Impact factor: 7.124

6.  Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.

Authors:  Astrid K Gnekow; Fabian Falkenstein; Stephan von Hornstein; Isabella Zwiener; Susanne Berkefeld; Brigitte Bison; Monika Warmuth-Metz; Pablo Hernáiz Driever; Niels Soerensen; Rolf-D Kortmann; Torsten Pietsch; Andreas Faldum
Journal:  Neuro Oncol       Date:  2012-08-31       Impact factor: 12.300

Review 7.  Pediatric low-grade gliomas: next biologically driven steps.

Authors:  David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300
  7 in total
  2 in total

Review 1.  Molecular alterations of low-grade gliomas in young patients: Strategies and platforms for routine evaluation.

Authors:  Iman Dandapath; Rituparna Chakraborty; Kavneet Kaur; Swati Mahajan; Jyotsna Singh; Mehar C Sharma; Chitra Sarkar; Vaishali Suri
Journal:  Neurooncol Pract       Date:  2021-08-23

2.  Genetic Alteration Analysis of IDH1, IDH2, CDKN2A, MYB and MYBL1 in Pediatric Low-Grade Gliomas.

Authors:  Orit Barinfeld; Alon Zahavi; Shirel Weiss; Helen Toledano; Shalom Michowiz; Nitza Goldenberg-Cohen
Journal:  Front Surg       Date:  2022-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.